These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 16297986)

  • 1. Catalytic activity of autoantibodies toward myelin basic protein correlates with the scores on the multiple sclerosis expanded disability status scale.
    Ponomarenko NA; Durova OM; Vorobiev II; Belogurov AA; Telegin GB; Suchkov SV; Misikov VK; Morse HC; Gabibov AG
    Immunol Lett; 2006 Feb; 103(1):45-50. PubMed ID: 16297986
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic value of cerebrospinal fluid anti-myelin basic protein in patients with multiple sclerosis.
    Warren KG; Catz I
    Ann Neurol; 1986 Jul; 20(1):20-5. PubMed ID: 2427010
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metal-dependent hydrolysis of myelin basic protein by IgGs from the sera of patients with multiple sclerosis.
    Polosukhina DI; Kanyshkova TG; Doronin BM; Tyshkevich OB; Buneva VN; Boiko AN; Gusev EI; Nevinsky GA; Favorova OO
    Immunol Lett; 2006 Feb; 103(1):75-81. PubMed ID: 16310860
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antibodies which block anti-myelin basic protein antibodies associated with development of experimental autoimmune encephalomyelitis in Wistar rats.
    Vilcaes AA; Degano AL; López PH; Nores GA; Roth GA
    J Neuroimmunol; 2005 Jul; 164(1-2):31-6. PubMed ID: 15950291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recognition and degradation of myelin basic protein peptides by serum autoantibodies: novel biomarker for multiple sclerosis.
    Belogurov AA; Kurkova IN; Friboulet A; Thomas D; Misikov VK; Zakharova MY; Suchkov SV; Kotov SV; Alehin AI; Avalle B; Souslova EA; Morse HC; Gabibov AG; Ponomarenko NA
    J Immunol; 2008 Jan; 180(2):1258-67. PubMed ID: 18178866
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrolysis of myelin basic protein by IgM and IgA antibodies from the sera of patients with multiple sclerosis.
    Polosukhina DI; Buneva VN; Doronin BM; Tyshkevich OB; Boiko AN; Gusev EI; Favorova OO; Nevinsky GA
    Med Sci Monit; 2005 Aug; 11(8):BR266-72. PubMed ID: 16049372
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Neurofilament protein light in multiple sclerosis].
    Zhang Y; Li X; Qiao J
    Zhonghua Yi Xue Za Zhi; 2007 Oct; 87(39):2745-9. PubMed ID: 18167263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Steroid protection in the experimental autoimmune encephalomyelitis model of multiple sclerosis.
    Garay L; Gonzalez Deniselle MC; Gierman L; Meyer M; Lima A; Roig P; De Nicola AF
    Neuroimmunomodulation; 2008; 15(1):76-83. PubMed ID: 18667803
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myelin basic protein and its antibodies in the cerebrospinal fluid in experimental allergic encephalomyelitis, multiple sclerosis and other diseases.
    Alvord EC; Hruby S; Shaw CM; Slimp J
    Prog Clin Biol Res; 1984; 146():359-63. PubMed ID: 6201907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anti-myelin antibodies modulate clinical expression of childhood multiple sclerosis.
    O'Connor KC; Lopez-Amaya C; Gagne D; Lovato L; Moore-Odom NH; Kennedy J; Krupp L; Tenembaum S; Ness J; Belman A; Boyko A; Bykova O; Mah JK; Stoian CA; Waubant E; Kremenchutzky M; Ruggieri M; Bardini MR; Rensel M; Hahn J; Weinstock-Guttman B; Yeh EA; Farrell K; Freedman MS; Iivanainen M; Bhan V; Dilenge M; Hancock MA; Gano D; Fattahie R; Kopel L; Fournier AE; Moscarello M; Banwell B; Bar-Or A
    J Neuroimmunol; 2010 Jun; 223(1-2):92-9. PubMed ID: 20381173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum autoantibodies to cell surface determinants in multiple sclerosis: a flow cytometric study.
    Lily O; Palace J; Vincent A
    Brain; 2004 Feb; 127(Pt 2):269-79. PubMed ID: 14662514
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular "negativity" may underlie multiple sclerosis: role of the myelin basic protein family in the pathogenesis of MS.
    Musse AA; Harauz G
    Int Rev Neurobiol; 2007; 79():149-72. PubMed ID: 17531841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Affinity and catalytic heterogeneity and metal-dependence of polyclonal myelin basic protein-hydrolyzing IgGs from sera of patients with systemic lupus erythematosus.
    Bezuglova AM; Konenkova LP; Doronin BM; Buneva VN; Nevinsky GA
    J Mol Recognit; 2011; 24(6):960-74. PubMed ID: 22038803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of a rat model of experimental autoimmune encephalomyelitis with human MBP as antigen.
    Guo L; Li Y; Lin H; Ji X; Li J; Que L; Zhang Y; Rong Y; Wang J
    Cell Mol Immunol; 2004 Oct; 1(5):387-91. PubMed ID: 16285900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody responses against galactocerebroside are potential stage-specific biomarkers in multiple sclerosis.
    Menge T; Lalive PH; von Büdingen HC; Cree B; Hauser SL; Genain CP
    J Allergy Clin Immunol; 2005 Aug; 116(2):453-9. PubMed ID: 16083805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoantibodies to the proteasome in monosymptomatic optic neuritis may predict progression to multiple sclerosis.
    Beyer NH; Milthers J; Bonde Lauridsen AM; Houen G; Lautrup Frederiksen J
    Scand J Clin Lab Invest; 2007; 67(7):696-706. PubMed ID: 17852796
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Measurement of immunoreactive myelin basic protein peptide (45-89) in cerebrospinal fluid.
    Gupta MK; Whitaker JN; Johnson C; Goren H
    Ann Neurol; 1988 Mar; 23(3):274-80. PubMed ID: 2454068
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-histone H1 IgGs from blood serum of systemic lupus erythematosus patients are capable of hydrolyzing histone H1 and myelin basic protein.
    Magorivska IB; Bilyy RO; Havrylyuk AM; Chop'yak VV; Stoika RS; Kit YY
    J Mol Recognit; 2010; 23(5):495-502. PubMed ID: 20583146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autoantibodies to myelin basic protein catalyze site-specific degradation of their antigen.
    Ponomarenko NA; Durova OM; Vorobiev II; Belogurov AA; Kurkova IN; Petrenko AG; Telegin GB; Suchkov SV; Kiselev SL; Lagarkova MA; Govorun VM; Serebryakova MV; Avalle B; Tornatore P; Karavanov A; Morse HC; Thomas D; Friboulet A; Gabibov AG
    Proc Natl Acad Sci U S A; 2006 Jan; 103(2):281-6. PubMed ID: 16387849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship of CSF neurotransmitter metabolite levels to disease severity and disability in multiple sclerosis.
    Markianos M; Koutsis G; Evangelopoulos ME; Mandellos D; Karahalios G; Sfagos C
    J Neurochem; 2009 Jan; 108(1):158-64. PubMed ID: 19014375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.